Ownership history in MORGAN STANLEY · 38 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in ADVERUM BIOTECHNOLOGIES INC (ADVM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 17,555 | -35,382 | -66.8% | 0.00% | $80K | — |
| 2025 Q2 | REDUCED | 52,937 | -15,780 | -23.0% | 0.00% | $114K | — |
| 2025 Q1 | REDUCED | 68,717 | -46,071 | -40.1% | 0.00% | $300K | — |
| 2024 Q4 | ADDED | 114,788 | +25,605 | +28.7% | 0.00% | $536K | — |
| 2024 Q3 | REDUCED | 89,183 | -40,076 | -31.0% | 0.00% | $626K | — |
| 2024 Q2 | REDUCED | 129,259 | -432,776 | -77.0% | 0.00% | $887K | — |
| 2024 Q1 | REDUCED | 562,035 | -4,588,361 | -89.1% | 0.00% | $7.9M | — |
| 2023 Q4 | REDUCED | 5,150,396 | -1,825,842 | -26.2% | 0.00% | $3.9M | — |
| 2023 Q3 | ADDED | 6,976,238 | +10,806 | +0.2% | 0.00% | $10.5M | — |
| 2023 Q2 | ADDED | 6,965,432 | +790 | +0.0% | 0.00% | $11.1M | — |
As of 2025 Q3 — sorted by position size